Drug for low sexual desire carries significant harms, FDA advisers find.
Moynihan
Ray
R
D001562:Benzimidazoles / Q000009:adverse effects*; D017277:Drug Approval; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000009:adverse effects*; D017697:Premenopause; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D001562:Benzimidazoles; D018377:Neurotransmitter Agents; C098107:flibanserin